Tao-Min Huang
Overview
Explore the profile of Tao-Min Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao H, Cheng C, Chen H, Chen J, Pan H, Huang T, et al.
Clin Kidney J
. 2025 Feb;
18(2):sfae385.
PMID: 39927258
Background: Dipeptidyl peptidase 4 inhibitors (DPP4is) are considered safe for use in patients with diabetes mellitus and kidney dysfunction. We explored whether usage of DPP4is in patients who recovered from...
2.
Chen J, Shiao C, Liu J, Su C, Pan H, Chun-Hao T, et al.
J Formos Med Assoc
. 2024 Oct;
PMID: 39379263
Background: Certain patient subpopulations requiring dialysis initiation show varied survival rates and chances of ending renal replacement therapy (RRT). Consensus clustering can help identify these subgroups and their dialysis outcomes....
3.
Pan H, Chen H, Teng N, Yeh F, Huang T, See C, et al.
JAMA Netw Open
. 2024 Mar;
7(3):e240351.
PMID: 38457183
Importance: The interplay among baseline kidney function, severity of acute kidney disease (AKD), and post-AKD kidney function has significant associations with patient outcomes. However, a comprehensive understanding of how these...
4.
Kao T, Huang C, Tsai C, Chen J, Huang T, Lin T, et al.
Acta Cardiol Sin
. 2023 Nov;
39(6):817-830.
PMID: 38022428
Background: The optimal strategy of percutaneous coronary intervention (PCI) for acute myocardial infarction (MI) complicated with cardiogenic shock (CS) remains controversial. We aimed to elucidate the renal and cardiovascular impact...
5.
Hsu W, Cheng Y, Yang T, Chang C, Lin Y, Lee C, et al.
Cardiorenal Med
. 2023 Sep;
13(1):310-323.
PMID: 37708880
Introduction: Sacubitril/valsartan (S/V) reduces all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF), but it may decline their estimated glomerular filtration rates (eGFR). In addition to eGFR,...
6.
Pan H, Yang S, Chiou T, Shiao C, Wu C, Huang C, et al.
Crit Care
. 2022 Nov;
26(1):349.
PMID: 36371256
Background: Several biomarkers have been proposed to predict the occurrence of acute kidney injury (AKI); however, their efficacy varies between different trials. The aim of this study was to compare...
7.
Chen J, Chen Y, Pan H, Hsieh C, Hsu T, Huang Y, et al.
Clin Kidney J
. 2022 May;
15(5):1027.
PMID: 35503545
[This corrects the article DOI: 10.1093/ckj/sfac011.].
8.
Chen J, Chen Y, Pan H, Hsieh C, Hsu T, Huang Y, et al.
Clin Kidney J
. 2022 May;
15(5):974-984.
PMID: 35498901
Background: Critically ill patients with severe acute kidney injury (AKI) requiring kidney replacement therapy (KRT) have a grim prognosis. Recently, multiple studies focused on the impact of KRT initiation time...
9.
Pan H, Huang T, Sun C, Chou N, Tsao C, Yeh F, et al.
EClinicalMedicine
. 2022 Jan;
44:101232.
PMID: 35059613
Background: Renal replacement therapy (RRT) is an effective rescue therapy for Type 1 cardiorenal syndrome (CRS). Previous studies have demonstrated that type 1 CRS patients with severe renal dysfunction were...
10.
Lin S, Kuo C, Huang T, Peng Y, Huang C, Tang S, et al.
Sci Rep
. 2021 Dec;
11(1):23833.
PMID: 34903821
The purpose of this study is to investigate the correlation between glomerular filtration rate (GFR) estimated by different renal function equations and non-vitamin K antagonist oral anticoagulant concentration. Atrial fibrillation...